Kanbi  Pharma  Teknoloji  Limite
173035-10-4
173035-10-4
173035-10-4

173035-10-4

Non pwodwi: 1,3-Bis(2,4,6-trimethylphenyl)imidazolinyòm klori
CAS:173035-10-4
MF:C21H29ClN2
MW:344.92
EINECS:
MDL Tèb:MFCD09039279

Voye rechèch
Dekri teren

Spesifikasyon:

Aparans Off-blan solid
Pite NLT 98%

 

Aplikasyon:

1,3-Bis (2,4,6-trimethylphenyl) imidazol idroklorid se sitou itilize nan reyaksyon sentèz òganik, espesyalman kòm yon katalis nan reyaksyon elektwochimik ak fotochimik. Li ka itilize pou reyaksyon tankou oksidasyon, rediksyon, carbonylation, reyajmantasyon, elatriye nan sentèz òganik.

 

Sinonim:

173035-10-4

1,3-Bis(2,4,6-trimethylphenyl)imidazolinyòm klori

klori 1,3-dimesityl-4,5-dihydro-1H-imidazol-3-

1,3-Bis(2,4,6-trimetilfenil)-4,5-klori dihydroimidazolium

klori 1,3-bis(2,4,6-trimethylphenyl)-4,{5-dihydroimidazol-1-

SIMes.HCl

1,3-klori Dimesitylimidazolidinium

C21H27ClN2

1,3-dimesityl-4,5-dihydro-1H-imidazol-3-yomchloride

1,3-Bis(2,4,6-trimethylphenyl)imidazolinyòm klori, 95%

1,3-bis(2,4,6-trimethyl-phenyl)-4,5-dihydro-1h-imidazol-3-klòri

 

Baj popilè: 173035-10-4, Lachin 173035-10-4 manifaktirè, founisè

Inquiry
goTop

(0/10)

clearall